Comparison of Coronary Risk Factors and Quality of Life in Coronary Artery Disease Patients With Versus Without Diabetes Mellitus

Pischke, Claudia R.; Weidner, Gerdi; Elliott-Eller, Melanie; Scherwitz, Larry; Merritt-Worden, Terri; Marlin, Ruth; Lipsenthal, Lee; Finkel, Robert J.; Saunders, Donald E.; McCormac, Patty; Scheer, Judith M.; Collins, R; Guarneri, Erminia; Ornish, Dean

doi:10.1016/j.amjcard.2005.11.051

Cited by 62 publications

(78 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The findings of our study are consistent with the existing literature in the United States [16][17][18]30]. It is worth noting that the primary focus of our study was the overall HRQoL difference of those with any MaVCCs compared with those without MaVCCs for patients with diabetes.…”

Section: Discussionsupporting

confidence: 91%

Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States

Qiu

Radican

et al. 2010

Qual Life Res

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 91%

Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States

Qiu

Radican

et al. 2010

Qual Life Res

View full text Add to dashboard Cite

show abstract

“…There have been reports in the literature showing that women present a higher degree of mental health impairment during the disease [24][25][26] . This characteristic might be associated to women's higher capacity of verbalization during the assessment 27 .…”

Section: Discussionmentioning

confidence: 99%

Qualidade de vida em pacientes com doença ateroclerótica coronariana grave e estável

Moriel¹,

Roscani²,

Matsubara³

et al. 2010

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

show abstract

“…An additional cause for concern is the increasing prevalence of such preventable diseases in developing countries. Although genetic predispositions exist, conditions such as cardiovascular disease (CVD), obesity, type 2 diabetes (T2D) and other metabolic-related disorders remain largely preventable by lifestyle choices [1,2]. The metabolic syndrome (MetS); a cluster of pathologies (including obesity, insulin resistance, high blood pressure and hyperlipidemia) which place an individual at a greater risk of developing T2D and CVD, is present in 25-50% of the U.S. population [3] and 5-36% of Europeans [4].…”

Section: Introductionmentioning

confidence: 99%

Phosphatidylcholine functional foods and nutraceuticals: A potential approach to prevent non‐alcoholic fatty liver disease

Duric

Sivanesan

Bakovic

2012

Euro J Lipid Sci & Tech

View full text Add to dashboard Cite

Non‐alcoholic fatty liver disease (NAFLD) is the most common liver condition in the developed world and may progress to more severe forms of disease such as cirrhosis or liver cancer. Thus, steps taken to reduce its prevalence through preventative nutritional approaches such as functional foods and nutraceuticals (FFN) should be pursued. It is well known that certain lipotropic nutrients such as choline and metabolites betaine and phosphatidylcholine (PC; lecithin) could prevent or alleviate fatty liver through a variety of mechanisms, including increased hepatic VLDL secretion. Animal and human studies have demonstrated clear protective effects of choline, betaine and PC for NAFLD as well as possible roles in CVD prevention from epidemiological data. Currently, choline consumption is below dietary recommendations due in large part to a general lack of understanding regarding the importance of this nutrient for human health. As lecithin is commonly added (in small amounts) in many processed foods due to its functional capabilities, it is projected that increasing its abundance in the food supply and increasing consumer education and acceptance of lecithin‐based functional foods and nutraceuticals may represent a progressive step towards preventing liver and whole‐body metabolic pathologies in many areas of the world.

show abstract

Comparison of Coronary Risk Factors and Quality of Life in Coronary Artery Disease Patients With Versus Without Diabetes Mellitus

Cited by 62 publications

References 21 publications

Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States

Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States

Qualidade de vida em pacientes com doença ateroclerótica coronariana grave e estável

Phosphatidylcholine functional foods and nutraceuticals: A potential approach to prevent non‐alcoholic fatty liver disease

Contact Info

Product

Resources

About